Loading...
Market
Number of biomarkers tracked by Function Health by 2024 end
2
Resolution / Starting Odds
Less than 100 • 33%
100 - 150 • 33%
More than 150 • 33%
Official Function Health metrics reported in press releases or company filings
Story
Function Health Secures $53 Million in Series A Funding to Revolutionize Preventative Healthcare
Jun 25, 2024, 04:30 PM
Function Health has secured $53 million in Series A funding, with backing from notable investors including the a16zBioHealth team. The company aims to revolutionize preventative healthcare by collecting over 100 biomarkers from lab tests, surpassing the typical annual physicals. Function Health integrates data from labs, electronic health records (EHRs), and wearables to provide personalized health insights. The company offers robust lab testing twice a year. Co-founder Mark Hyman emphasizes the importance of empowering individuals to take control of their health outside the doctor's office, highlighting the role of AI and extensive health data in achieving this goal.
View original story
Similar markets
Yes • 50%
No • 50%
Cardiovascular disease • 25%
Diabetes • 25%
Cancer • 25%
Other • 25%
Highly successful • 33%
Moderately successful • 33%
Not successful • 33%
Less than 100,000 • 33%
100,000 to 200,000 • 33%
More than 200,000 • 33%
0-5 • 25%
6-10 • 25%
11-15 • 25%
16 or more • 25%
Less than 10 • 25%
10 to 50 • 25%
51 to 100 • 25%
More than 100 • 25%
Widely adopted in clinical settings • 25%
Limited adoption in research settings • 25%
Not adopted • 25%
Other • 25%
0-10 hospitals • 33%
11-20 hospitals • 33%
21+ hospitals • 34%
Less than 50 • 25%
50 to 200 • 25%
201 to 500 • 25%
More than 500 • 25%
Widely adopted (>75% of clinics) • 25%
Moderately adopted (50-75% of clinics) • 25%
Sparsely adopted (25-50% of clinics) • 25%
Rarely adopted (<25% of clinics) • 25%
Market share increases • 25%
Market share remains the same • 25%
Market share decreases • 25%
Foresight exits cancer-detection market • 25%